News

January 23, 2018January 23, 2018

Adcetris Combo Effective as First-line Treatment for Hodgkin’s Lymphoma, Trial Results Show

News

Adcetris (brentuximab vedotin) in combination with chemotherapy is a valuable treatment option for patients with previously untreated advanced Hodgkin’s lymphoma, researchers said after revealing data from a Phase 3 clinical ... Read more

January 23, 2018January 23, 2018

Celgene to Acquire Juno for $9 Billion, Picking Up Potential CAR T-cell Lymphoma Therapies

News

Celgene will buy Juno Therapeutics for $9 billion in a deal that gives Celgene access to an experimental gene therapy for treating people with relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma. ... Read more

January 22, 2018

Study Suggests Link Between Chernobyl and 10 Rare Eye Cancer Cases in New York City

News

The ultra-rare vitreoretinal lymphoma of 10 people in New York City could stem from the long-term effects of the 1986 Chernobyl nuclear disaster, a study suggests. The report, “A cluster of ... Read more

January 19, 2018January 19, 2018

Phase 1/2 Trial to Test Yescarta-Utomilumab Combo in Refractory Large B-cell Lymphoma

News

A new multicenter Phase 1/2 trial will evaluate an immunotherapy combination of Yescarta (axicabtagene ciloleucel) and utomilumab for the treatment of patients with refractory large B-cell lymphoma. The trial, part of a clinical ... Read more

January 18, 2018January 18, 2018

FDA Promises Rapid Review of Kymriah for Diffuse Large B-cell Lymphoma

News

The U.S. Food and Drug Administration (FDA) will prioritize the regulatory review of Novartis’ application to use Kymriah (tisagenlecleucel) for the treatment of adults with relapsed or refractory diffuse large ... Read more

January 17, 2018January 17, 2018

New Blood Stem Cell Harvest Method Could Speed Up Transplants

News

A new method of releasing blood stem cells from the bone marrow into the blood may lead to more rapid and efficient stem cell transplants in lymphoma patients. If confirmed ... Read more

January 16, 2018January 16, 2018

New CAR T-cell Production Method May Offer Faster, More Targeted Therapies, Study Reports

News

A new method for growing the T-cells used in lymphoma immunotherapies may some day lead to treatments that are faster and do a better job of honing in on a ... Read more

January 15, 2018January 15, 2018

Age Alone Should Not Exclude Lymphoma Patients From Stem Cell Transplants, Researchers Argue

News

Older lymphoma patients should not be excluded from treatment with stem cell transplants based solely on their age, researchers at Massachusetts General Hospital have concluded after reviewing several patient outcomes. The ... Read more

January 12, 2018

FDA Clears Voruciclib for Phase 1 Trial as Potential Treatment for Certain B-cell Malignancies

News

The U.S. Food and Drug Administration (FDA) has cleared the way for MEI Pharma to launch a Phase 1 study of voruciclib, its oral CDK9 inhibitor, to treat people with ... Read more

January 11, 2018

LLS Receives $5M to Support Research Programs in Mantle Cell Lymphoma

News

The Leukemia & Lymphoma Society (LLS) received a $5 million donation from the Sarah Cannon Fund to support two U.S. programs researching mantle cell lymphoma (MCL). The Sarah Cannon Fund at ... Read more